[1] Hodde J. Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng.2002;8(2):295-308.
[2] Badylak SF,Gilbert TW.Immune response to biologic scaffold materials. Semin Immunol.2008;20(2):109116.
[3] Macher BA,Galili U.The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance.Biochim Biophys Acta. 2008;1780:75-88.
[4] Cooper DK,Koren E,Oriol R.Oligosaccharides and discordant xenotransplantation.Immunol Rev.1994;141:31-58.
[5] Good AH,Cooper DKC,Malcolm AJ,et al.Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc.1992;(24):559.
[6] Oriol R,Ye Y,Koren E,et al.Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.Transplantation.1993;56:1433-1442.
[7] Sandrin MS,Vaughan HA,Dabkowski PL,et al.Anti-pig IgM antibodies in human serum predominantly react with Gal (α1-3)Gal epitopes.Proc Natl Acad Sci.1995;(90):11391-11395.
[8] Bach FH,Robson SC,Winkler H,et al.Barriers to xenotransplantation. Nat Med.1995;1(9):869-873.
[9] Hanfland P,Kordowicz M,Peter-Katalinic J,et al.Structure elucidation of blood group B-like and I-active ceramide eicosa- and pentacosa-saccharides from rabbit erythrocyte membranes by combined gas chromatography-mass spectrometry; electron-impact and fast-atom-bombardment mass spectrometry; and two dimensional correlated, relayed- coherence transfer, and nuclear overhauser effect 500-MHz 1H-N.m.r. spectroscopy.Carbohydr Res. 1988;178(1):1-21.
[10] Dorland L,van Halbeek H,Vliegenthart JF.The identification of terminal α(1-3)-linked galactose in N-acetyllactosamine type of glycopeptides by means of 500-MHz 1 H-NMR spectroscopy. Biochem Biophys Res Commun.1984;122:859-866.
[11] Kim YG,Kim SY,Hur YM,et al.The identification and characterization of xenoantigenic nonhuman carbohydrate sequences in membrane proteins from porcine kidney. Proteomics.2006;6(4):1133-1142.
[12] Hendricks SP,He P,Stults CL,et al.Regulation of the expression of Gal α1-3Galβ1-4GlcNAc glycosphingolipids in kidney.J Biol Chem.1990;265(29):17621-17626.
[13] Uemura K,Yuzawa M,Taketomi T.Characterization of major glycolipids in bovine erythrocyte membrane.J Biochem. 1978; 83(2):463-471.
[14] He P,Hu J,Macher BA.Glycosphingolipids of rabbit, sheep, and pig thymus .Arch Biochem Biophys. 1993;305(2):350-361.
[15] Spiro RG,Bhoyroo VD.Occurrence of α-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units.J Biol Chem.1984;(259):9858-9866.
[16] Arumugham RG,Hsieh TC,Tanzer ML,et al.Structures of the asparagine-linked sugar chains of laminin.Biochim Biophys Acta.1986;(883):112-126.
[17] Mohan PS,Spiro RG.Macromolecular organization of basement membranes. Characterization and comparison of glomerular basement membrane and lens capsule components by immunochemical and lectin affinity procedures. J Biol Chem.1986;261(9):4328-4336.
[18] Thall A,Galili U.Distribution of Gal α1-3Galβ1-4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry. 1990;(29):3959-3965.
[19] 邢力,郭礼和.异种器官移植中的Galα(1,3)Gal抗原表位的研究进展[J].细胞生物学杂志,2001,23(4):191-195.
[20] Galili U,Sholehet SB,Kobrin E,et al.Man, apes and old world monkeys differ from other mammals in the expression of -galactosyl epitopes on nucleated cells.J Biol Chem. 1988; 263(3):17755-17762.
[21] Larsen RD,Rivera-Marrero CA,Ernst LK,et al. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J Biol Chem. 1990; 265(12):7055-7061.
[22] Galili U,Swanson K.Gene sequences suggest inactivation of alpha-1, 3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci. 1991; (88):7401-7404.
[23] Henion TR,Macher BA,Anaraki F,et al.Defining the minimal size of catalytically active primate α1,3 galactosyltransferase: structure function studies on the recombinant truncated enzyme.Glycobiology.1994;4(2):193-202.
[24] Galili U,Rachmilewitz EA,Peleg A,et al.A unique natural human IgG antibody with anti-alpha-galactosyl specificity.J Exp Med.1984;160(5):1519-1531.
[25] Galili U,Mandrell RE,Hamadeh RM,et al.Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora.Infect Immun.1988;56(7):1730-1737.
[26] Galili U,Macher BA,Buehler J,et al.Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.J Exp Med.1985;162(2): 573-582.
[27] McPherson TB,Liang H,Record RD,et al.Galalpha(1,3)Gal epitope in porcine small intestinal submucosa.Tissue Eng. 2000;6:233-239.
[28] 李涛,李幼平,杨志明.猪到人异种移植抗原与移植免疫研究[J].中国修复重建外科杂志,1998,12(1):42.
[29] Chen RH,Mitchell RN,Kadner A,et al.Differential galactose α(1,3) galactose expression by porcine cardiac vascular endothelium. Xenotransplantation.1999;6(3):169-172.
[30] McKenzie IFC,Xing PX,Vaughan HA,et al.Distribution of the major xenoantigen (gal(α1-3)gal) for pig to human xenografts.Transplant Immunol.1994;2(2):81-86.
[31] Feng W,Lian Y,Zhou Z,et al.Distribution of the alpha-gal epitope on adult porcine bone tissue.Transplant Proc. 2006; 38(7):2247-2251.
[32] Lee HI,Kim MK,Oh JY,et al. Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation. Xenotransplantation.2007;14(6):612-618.
[33] 陈学英,原林,李靖,等.异种骨移植材料的制备与生物学评价[J].解剖学杂志,2009,32(2):226-229.
[34] 陈华勇,柏树令,崔春兰.组织工程小血管支架应用于异种血管移植的可行性[J].中国组织工程研究与临床康复,2009,13(38): 7429-7432.
[35] Santer UV,DeSantis R,Hard KJ,et al.N-linked oligosaccharide changes with oncogenic transformation require sialylation of multiantennae.Eur J Biochem.1989;181(1):249-260.
[36] Ito M,Suzuki E,Naiki M,et al.Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system.Int J Cancer.1984;34(5):689-697.
[37] Cummings RD,Kornfeld S.The distribution of repeating [Galβ1,4GlcNAcβ1,3] sequences in asparagine-linked oligosaccharides of the mouse lymphoma cell lines BW5147 and PHAR 2.1.J Biol Chem.1984;259 (10):6253-6260.
[38] 常宏宇,章杨培.α1,3-半乳糖转移酶及其相关糖基转移酶的研究进展[J].军事医学科学院院刊,2008,32(5):478-481.
[39] 史新立,谭芳奕,王召旭,等.疯牛病病原体研究及动物源性医疗器械产品安全性思考[J].中国修复重建外科杂志,2006,20(11): 1138-114.
[40] 付海洋,奚廷斐.生物源性医疗器械的病毒安全性研究[J].药物警戒,2005,2 (2):78-81.
[41] 杨晓芳,奚廷斐.医疗器械免疫源性现状概述[J].中国医疗器械信息,2007,13(6):50-51.
[42] Schoen FJ,Levy RJ.Bioprosthetic heart valve failure: Pathology and pathogenesis.Cardiol Clin.1989;2(4):717-739.
[43] Schoen FJ,Levy RJ.Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention. Ann Thorac Surg.2005;79(3):1072-1080.
[44] Girardo MN,Torrianni M,Dillehay D,et al.Role of glutaraldehyde in calcification of porcine heart valves: Comparing cusp and wall J Biomed Mater Res. 1995;29(7):793-801.
[45] Silver MM,Pollock J,Silver MD,et al.Calcification in porcine xenograft valves in children.Am J Cardiol.1980;45(3): 685-689.
[46] Jamieson W RE,Rosado LJ,Munro AI,et al. Carpentier-Edwards standard porcine bioprosthesis: Primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg.1988;46(2):155-162.
[47] Cohn LH,Colins JJ,DiSesa VJ,et al.Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements.Ann Thorac Surg.1989;210:435-442.
[48] Grunkemeier GL,Jamieson WR,Miller DC,et al.Actuarial versus actual risk of porcine structural valve deterioration.J Thorac Cardiovasc Surg.1994;108(4):709-718.
[49] Manji RA,Zhu LF,Nijjar NK,et al.Glutaraldehyde fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection.Circulation.2006;114:318-327.
[50] Shaddy RE,Hawkins JA.Immunology and failure of valved allografts in children.Ann Thorac Surg.2002;74:1271-1275.
[51] Nam J,Choi SY,Sung SC,et al.Changes of the Structural and Biomechanical Properties of the Bovine Pericardium after the Removal of α-Gal Epitopes by Decellularization and α-Galactosidase Treatment.Korean J Thorac Cardiovasc Surg. 2012;45(6):380-389.
[52] Human P,Zilla P.Characterization of the immune response to valve bioprostheses and its role in primary tissue failure.Ann Thorac Surg.2001;71(5 Suppl):S385-S388.
[53] Park S,Kim WH,Choi SY,et al.Removal of Alpha-Gal Epitopes from Porcine Aortic Valve and Pericardium using Recombinant Human Alpha Galactosidase A.J Korean Med Sci.2009;24(6):1126-1131.
[54] Naso F,Gandaglia A,Iop L,et al.Alpha-Gal detectors in xenotransplantation research: a word of caution. Xenotransplantation.2012;(19):215-220.
[55] Kasimir MT,Rieder E,Seebacher G,et al.Presence and elimination of the xenoantigen Gal (1, 3) gal in tissue-engineered heart valves.Tissue Eng.2005;11: 1274-1280.
[56] Park CS,Park SS,Choi SY,et al.Anti α-Gal Immune Response Following Porcine Bioprosthesis Implantation in Children.J Heart Valve Dis.2010;19:124-130.
[57] Mangold A,Szerafin T,Hoetzenecker K,et al.Alpha-Gal specific IgG immune response after implantation of bioprostheses.Thorac Cardiovasc Surg.2009;57:191-195.
[58] Konakci KZ,Bohle B,Blumer R,et al.Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery.Eur J Clin Invest.2005;35(1):17-23.
[59] Stone KR,Walgenbach AW,Abrams JT,et al.Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection. Transplantation. 1997;63(5):640-645.
[60] Ansaloni L,Cambrini P,Catena F,et al.Immune response to small intestinal submucosa (surgisis) implant in humans: preliminary observations.J Invest Surg. 2007;20(4):237-241.
[61] Zhu M,Zhang W,Liu F,et al.Resistance to anti-xenogeneic response by combining silencing with HO-1 upregulation. Transpl Immunol.2008;19(3-4):202-208.
[62] 彭珊瑛,王文杰.异种移植中Galα(1,3)Gal抗原的研究近况[J].生理科学进展, 2003,34(3):248-250.
[63] Luo Y,Wen J,Luo C,et al.Pig xenogeneic antigen modification with green coffee bean alpha-galactosidase. Xenotransplantation.1999;6(4):238-248.
[64] Cairns T,Hammenlmann W,Gray D,et al.Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human anti-species antibodies.Transplant Proc.1994;26(3):1279-1280.
[65] LaVecchio JA,Dunne AD,Edge ASB.Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation.1995;60(8):841.
[66] Stone KR,Abdel-Motal UM,Walgenbach AW,et al.Replacement of human anterior cruciate ligaments with pig ligament: A Model for Anti-Non-Gal Antibody Response in Long-Term Xenotransplantation. Transplantation.2007;83(2): 211-219.
[67] Sandrin MS,Fodor WL,Cohney S,et al. Reduction of the major porcine xenoantigen Gal (1, 3) Gal by expression of α (1,2) fucosyltransferase.Xenotransplantation.1996;3(1):134-140.
[68] Cohney S,Mckenzie IF,Patton K. Down-regulation of Gal alpha(1,3) Gal expression by alpha 1,2-fucosyltransferase: Further Characterization of alpha 1,2-Fucosyltransferase Transgenic Mice.Transplantation.1997;64(3):495-500.
[69] Sandrin MS,Fodor WL,Mouthtouris E,et al.Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis.Nat Med.1995;1:1261-1267.
[70] Sepp A,Skacel P, Lindstedt R,et al.Expression of α-1,3-Galactose and Other Type 2 Oligosaccharide Structures in a Porcine Endothelial Cell Line Transfected with Human α-1,2-Fucosyltransferase cDNA.J Biol Chem. 1997;272(37): 23104-23110.
[71] Tanemura M,Miyagawa S,Koyota S,et al.Reduction of the major swine xenoantigen GALα(1,3)GAL by transfection of N-acetylglucosaminyl transferase III (GnT-III) gene.J Biol Chem.1998;273(26):16421-16425.
[72] 宫锋,章扬培,贾廷军,等.联合转导人α1,3-半乳糖苷酶和α1,2-岩藻糖转移酶基因清除猪细胞表面异种抗原[J].科学通报, 2006, 60(22):2484-2488.
[73] Galili U.The gal epitope (Gal 1-3 Gal 1-4 GlcNAc-R) in xenotransplatation. Biochimie.2001;(83):557-563.
[74] Lai L,Kolber-Simonds D,Park KW,et al.Production of -1, 3-Galactosyltransferase knockout pigs by nuclear transfer cloning.Science.2002;295:1089-1092.
[75] Dai Y,Vaught TD,Boone J,et al.Targeted disruption of the alpha 1,3-galactosyltransferase gene in cloned pigs.Nat Biotechnol.2002;1:251-255.
[76] Phelps CJ,Koike C,Vaught TD,et al.Production of alpha 1,3-galactosyltransferase-deficient pigs. Science. 2003;299 (5605):411-414.
[77] Peter BP,Goldstein IJ.The use of fluorescein-conjugated Banderiaea simplicifolia B4-lectin as a histochemical reagent for the detection of alpha-D-galactopyranosyl groups. Their occurrence in basement membranes.Exp Cell Res. 1979;120: 321-334.
[78] Galili U,Latemple DC,Radic MZ.A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody.Transplantation. 1998;65: 1129-1132.
[79] Naso F,Gandaglia A,Iop L,et al.First quantitative assay of alpha-Gal in soft tissues: Presence and distribution of the epitope before and after cell removal from xenogeneic heart valves.Acta Biomaterialia.2011;7:1728-1734.
[80] 冯卫,付丽,福兴,等.Alpha-Gal异种移植抗原在猪骨中的分布研究[J].中国实验诊断学,2009,13(3):343-345.
[81] 范晶,吴丹,郭亚芬,等.三个品种猪α-Gal抗原表位的免疫组化分析[J].实用预防医学,2010,17(10):2068-2072. |